Focus 20 November 2019

Regional Focus - Asia

Growth in research coming from Asia, specifically China, over recent years has been pronounced. China has now surpassed the US in terms of global publications output and is challenging the US and Europe in terms of R&D investment.

Not only has the volume of research increased but the quality of research has also improved with the volume of citations increasing and a greater percentage of top cited authors now coming from this region.

This collection showcases a selection of top cited articles published in Leukemia from authors hailing from this region.

Content

Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma
- M Fujisawa
- M Sakata-Yanagimoto
- S Chiba
Original ArticleOpen Access23 Aug 2017 Leukemia
Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia
- S Fujita
- D Honma
- I Kitabayashi
Original Article27 Sep 2017 Leukemia
Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib
- K Shide
- T Kameda
- K Shimoda
Original ArticleOpen Access3 Nov 2016 Leukemia
High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients
- J Pan
- J F Yang
- C R Tong
Original Article15 May 2017 Leukemia
Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia
- H Wu
- C Hu
- Q Liu
Original Article13 Jul 2015 Leukemia
Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia
- V Madan
- P Shyamsunder
- H P Koeffler
Original ArticleOpen Access11 Apr 2016 Leukemia
Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study
- Y Yang
- Y-J Zhang
- Y-X Li
Original Article20 Feb 2015 Leukemia
SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS
- D Inoue
- J Kitaura
- T Kitamura
Original Article13 Oct 2014 Leukemia
Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients
- R Kihara
- Y Nagata
- T Naoe
Original Article3 Feb 2014 Leukemia
Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia
- M Matsunawa
- R Yamamoto
- S Ogawa
Original Article18 Feb 2014 Leukemia
CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells
- M Takahashi
- Y Matsuoka
- Y Sonoda
Original ArticleOpen Access5 Nov 2013 Leukemia
Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma
- H Tamura
- M Ishibashi
- K Ogata
Original Article25 Jul 2012 Leukemia
Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells
- Y Yu
- L Yang
- L Cao
Original Article7 Mar 2012 Leukemia
HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells
- L Liu
- M Yang
- L Cao
Original Article7 Oct 2010 Leukemia
The role of microRNA-150 as a tumor suppressor in malignant lymphoma
- A Watanabe
- H Tagawa
- K Sawada
Original Article19 Apr 2011 Leukemia
Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress
- M Ri
- S Iida
- R Ueda
Original Article17 Jun 2010 Leukemia
Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1
- Y Zhu
- Z Sun
- R C Zhao
Original Article15 Jan 2009 Leukemia
Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations
- N Niitsu
- M Okamoto
- M Hirano
Original Article8 Jan 2009 Leukemia
Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F
- K Shide
- H K Shimoda
- K Shimoda
Original Article22 Nov 2007 Leukemia
CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL
- Y Kong
- S Yoshida
- F Ishikawa
Original Article17 Apr 2008 Leukemia

Regional Focus - Asia

Content

Activation of RHOA–VAV1 signaling in angioimmunoblastic T-cell lymphoma

Dual inhibition of EZH1/2 breaks the quiescence of leukemia stem cells in acute myeloid leukemia

Calreticulin mutant mice develop essential thrombocythemia that is ameliorated by the JAK inhibitor ruxolitinib

High efficacy and safety of low-dose CD19-directed CAR-T cell therapy in 51 refractory or relapsed B acute lymphoblastic leukemia patients

Discovery of a BTK/MNK dual inhibitor for lymphoma and leukemia

Comprehensive mutational analysis of primary and relapse acute promyelocytic leukemia

Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study

SETBP1 mutations drive leukemic transformation in ASXL1-mutated MDS

Comprehensive analysis of genetic alterations and their prognostic impacts in adult acute myeloid leukemia patients

Haploinsufficiency of Sf3b1 leads to compromised stem cell function but not to myelodysplasia

CD133 is a positive marker for a distinct class of primitive human cord blood-derived CD34-negative hematopoietic stem cells

Marrow stromal cells induce B7-H1 expression on myeloma cells, generating aggressive characteristics in multiple myeloma

Targeting microRNA-30a-mediated autophagy enhances imatinib activity against human chronic myeloid leukemia cells

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells

The role of microRNA-150 as a tumor suppressor in malignant lymphoma

Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress

Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1

Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations

Development of ET, primary myelofibrosis and PV in mice expressing JAK2 V617F

CD34+CD38+CD19+ as well as CD34+CD38−CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL

Search

Quick links